Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma

Mingyu Zhu(Tianjin Medical University Cancer Institute and Hospital), Hao Jin(Tongji University), Haiyan Cui(Tongji University), Kuo Zhao(Tianjin Medical University Cancer Institute and Hospital), Lu Zhang(Henan University), Xiaochen Jia
Translational Cancer Research
December 2, 2021
Cited by 19


Related Papers